ArticleBMC pulmonary medicine2025
Is the pulmonary artery to aorta ratio a prognostic indicator in acute exacerbation of COPD?
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The effect of pectoralis muscle area and nutritional index on the need for NIV treatment in COPD patients with acute respiratory failure.Irish journal of medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimTo evaluate whether the pulmonary artery to ascending aorta diameter ratio (PA/A ratio), measured via thoracic computed tomography (CT), is associated with poor clinical outcomes and mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD).
methodsThis retrospective study included 486 COPD patients admitted between 2017 and 2023 with available thoracic CT or CT angiography at admission. PA and aortic diameters were measured by radiologists, and PA/A ratios were calculated. Clinical parameters including blood gas values, need for non-invasive (NIMV) or invasive mechanical ventilation (IMV), and mortality data were collected. Statistical analyses included Mann-Whitney U, Chi-square, Spearman correlation, and ROC curve analysis.
resultsAmong the 486 patients, 451 had a PA/A ratio ≤ 1, and 35 had a PA/A ratio > 1. The median PA/A ratio was 0.80 [IQR: 0.72-0.88]. Higher PA/A ratios were significantly associated with female gender, acidosis, hypercapnia, and increased need for both NIMV and IMV (p < 0.05). ROC analysis identified a PA/A cut-off of > 0.80 for predicting IMV need (sensitivity 71.43%, specificity 46.02%). No significant difference was found in early or late mortality between PA/A groups. RDW and PCO₂ levels were higher in patients with PA/A > 1, while MCV was lower.
conclusionOne of the most striking findings of this study is that the PA/A ratio was not directly correlated with early or late mortality; however, it showed a significant positive correlation with the need for both non-invasive and invasive mechanical ventilation as well as presence of hypercapnia. This suggests that the PA/A ratio may be a valuable marker for predicting clinical deterioration and the need for ventilatory support rather than mortality itself.The PA/A ratio may serve as a valuable non-invasive marker in the prognostic assessment of COPD exacerbations, especially when the ratio exceeds 0.8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.